Press release
Neurological Biomarkers Market 2033: Size, Growth, and Industry Forecast Analysis
Neurological Biomarkers Global Market Report 2024
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12677&type=smp
According to The Business Research Company's, The neurological biomarkers market size has grown rapidly in recent years. It will grow from $9.46 billion in 2023 to $10.63 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, aging population, drug development needs, increased funding for neurological research, personalized medicine.
The neurological biomarkers market size is expected to see rapid growth in the next few years. It will grow to $17.18 billion in 2028 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to biomarkers for early detection, biosensors, wearable devices, global health initiatives, patient-centric approach. Major trends in the forecast period include technological innovation in imaging, rapid advances in omics technologies, integration of artificial intelligence (ai), real-world evidence in biomarker validation, advancements in diagnostic technologies, collaboration between industry and research institutions.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report
Market Drivers and Trends:
The increasing prevalence of neurological diseases is expected to propel the growth of the neurological biomarker market going forward. Neurological illnesses affect the brain, spinal cord, and all of the body's other nerves. Parkinson's disease is a neurodegenerative disorder affecting the neurological system and the areas of the body that are under the control of the nerves. Neurological biomarkers help provide an early diagnosis of Parkinson's disease using pathological, biochemical, and genetic testing. For instance, in December 2022, according to the Parkinson's Foundation, a US-based non-profit organization, the number of new diagnoses of Parkinson's disease reached 90,000 in 2022, up from 60,000 per year in 2021. Therefore, the increasing prevalence of neurological diseases is driving the growth of the neurological biomarker market.
Major companies operating in the neurological biomarkers market are forming partnerships to develop new products and strengthen their positions in the market. Collaborations and partnerships in the neurological biomarkers market foster innovation, leverage complementary expertise, and accelerate the development and commercialization of advanced therapies by combining resources and capabilities. For instance, in July 2022, NeuroSense Therapeutics Ltd., an Israel-based company developing treatments for severe neurodegenerative diseases partnered with NeuraLight, an Israel-based company developing objective and sensitive biomarkers for neurological disorders. This collaboration is to identify oculometric indicators for Amyotrophic Lateral Sclerosis (ALS) through the application of AI (Artificial Intelligence) and ML (Machine Learning). The partnership, which comes after NeuraLight's $25 million Series A financing, is to enhance the discovery and application of ALS digital indicators in a parallel study. This will be the collaboration's first clinical trial. The partnership is centered on the application of oculometric digital indicators, which may allow for patient classification and boost clinical trial success rates.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Thermos Fisher Scientific Inc., AstraZeneca Plc, Abbott Laboratories, Boehringer Ingelheim International GmbH, Becton Dickinson and Company, Agilent Technologies Inc., Grifols S.A., Eisai Co. Ltd., PerkinElmer Inc., Illumina Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Mallinckrodt Plc, Qiagen N.V., Luminex Corporation, Siemens Healthineers, Olink Proteomics, Meso Scale Diagnostics, Quanterix Corp., Fujirebio, Cisbio Bioassays SAS, NeuroVision Imaging, Proteome Sciences Plc, Acumen Pharmaceuticals.
Neurological Biomarkers Market 2024 Key Insights:
• The neurological biomarkers market size is expected to see rapid growth in the next few years. It will grow to $17.18 billion in 2028 at a compound annual growth rate (CAGR) of 12.7%.
• Rising Prevalence Of Neurological Diseases Fuels Momentum In Neurological Biomarker Market
• Strategic Collaborations Drive Innovation In Neurological Biomarkers Market
• North America was the largest region in the neurological biomarkers market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12677&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurological Biomarkers Market 2033: Size, Growth, and Industry Forecast Analysis here
News-ID: 3763005 • Views: …
More Releases from The Business research company
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period?
The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to…
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since…
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, …
The high voltage aluminum electrolytic capacitors report describes and explains the high voltage aluminum electrolytic capacitors market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global high voltage aluminum electrolytic capacitors market reached a value of nearly $4.10301 billion in 2024, having grown at a compound annual growth…
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers …
The vertical market software report describes and explains the vertical market software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global vertical market software market reached a value of nearly $152.61027 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.11% since 2019.…
More Releases for Neurological
Major Growth Driver Identified in 2025 Neurological Biomarkers Market: Rising Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurological Biomarkers Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of neurological biomarkers has seen a swift augmentation in the past few years. Projected to escalate from $10.7 billion in 2024 to $11.96 billion in 2025, it holds a compound annual growth…
Neurological Biomarkers Market : An Overview
Introduction:
Neurological biomarkers are biological markers that provide insight into the physiological, pathological, and pharmacological responses of the nervous system. These biomarkers play a critical role in diagnosing, monitoring, and treating neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. With growing advancements in genomics, proteomics, and molecular biology, neurological biomarkers have emerged as essential tools in precision medicine, allowing for early detection and personalized treatment plans for…
Neurological Biomarkers Market: An Overview
Introduction:
Neurological biomarkers refer to measurable indicators that can be used to detect or monitor neurological diseases or disorders. These biomarkers provide critical insights into the diagnosis, progression, and treatment of neurological conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury. Neurological biomarkers are typically measured in bodily fluids like cerebrospinal fluid (CSF), blood, or even imaging techniques like MRI. With advancements in molecular biology, genomics, and…
Nurturing Neurological Wellness: Insights into the Global Neurological Disorder …
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Neurological disorders represent a significant healthcare challenge, affecting millions worldwide and encompassing a diverse spectrum of conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis, among others. In the quest for effective management and treatment, pharmaceutical interventions play a pivotal role. As we embark on a journey to explore the global neurological disorder drugs market, we unravel the complex interplay of resin types, applications, technologies, end-use industries, and…
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040
This latest report researches the industry structure, sales, revenue,…
Neurological Disorder Drugs Market - Advancing Neurological Health through Innov …
Newark, New Castle, USA - new report, titled Neurological Disorder Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Neurological Disorder Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Neurological Disorder Drugs market. The report offers an overview of…
